Detection of nucleic acids by type-specific hybrid capture method

• US 7,439,016 B1
• Filed: 06/15/2000
• Issued: 10/21/2008
• Est. Priority Date: 06/15/2000
• Status: Expired due to Fees

• Current Assignee: Digene Corporation (Qiagen NV)
• Original Assignee: Digene Corporation (Qiagen NV)
• Inventors: Troy, John, Lorincz, Attila, Tan, Yanglin, Anthony, James
• Primary Examiner(s): Chunduru; Suryaprabha
• Application Number:
  US09/594,839
• Time in Patent Office: 3,050 Days
• Field of Search: 435/6, 536/24.32, 536/24.31
• US Class Current: 435/6.1
• CPC Class Codes: C12Q 1/6832 Enhancement of hybridisation reaction
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574
• CPC Class Codes: C12Q 1/705 for herpetoviridae, e.g. herpes simplex, varicella zoster
• CPC Class Codes: C12Q 1/708 for papilloma
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2565/519 characterised by the capture moiety being a single stranded oligonucleotide
• CPC Class Codes: C12Q 2565/543 characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

Target-specific hybrid capture (TSHC) provides a nucleic acid detection method that is not only rapid and sensitive, but is also highly specific and capable of discriminating highly homologous nucleic acid target sequences. The method produces DNA-RNA hybrids which can be detected by a variety of methods.

Claims

1. A method of detecting a target nucleic acid comprising:

a) hybridizing a single-stranded target nucleic acid to a capture sequence probe and a signal sequence probe to form a hybrid complex comprising double-stranded hybrids between said capture sequence probe and a portion of the target nucleic acid, and between said signal sequence probe and a portion of the target nucleic acid, wherein the capture sequence probe and the signal sequence probe hybridize to non-overlapping regions within the target nucleic acid and do not hybridize to each other, wherein the signal sequence probe is unlabeled; and

b) adding a blocker probe to the hybridization reaction, wherein said blocker probe hybridizes to excess non-hybridized capture sequence probes;

c) capturing the capture sequence probe;

target portion of said hybrid complex to form a bound hybrid complex; and

d) detecting the bound double-stranded hybrid complex, thereby detecting the target nucleic acid.

3. The method of claim 1 or 2, wherein the capture sequence probe is modified with at least one ligand.

5. The method of claim 3, wherein the ligand is biotin.

6. The method of claim 5, wherein the capture sequence probe is linear having a 5′

and 3′

end, wherein both the 5′ and

the 3′

ends are biotinylated.

7. The method of claim 1 or 2, wherein the capture sequence probe and the signal sequence probe hybridize to regions of the target nucleic acid, wherein the regions are less than 3 kilobases apart.

8. The method of claim 1 or 2, wherein the capture sequence probe and the signal sequence probe hybridize to regions of the target nucleic acid, wherein the regions are less than 500 bases apart.

9. The method of claim 1 or 2, wherein the capture sequence probe is a fusion of two or more sequences complementary to different regions of the target nucleic acid or to different target molecules.

10. The method of claim 1 or 2, wherein the double-stranded hybrid formed is a DNA-RNA hybrid.

11. The method of claim 1 or 2, further comprising the step of forming single-stranded DNA prior to the hybridization step.

12. The method of claim 1 or 2, wherein hybridization of the capture sequence probe and the signal sequence probe to the target nucleic acid are performed sequentially.

13. The method of claim 1 or 2, wherein step a) and step b) are performed simultaneously.

14. The method of claim 1 or 2, wherein the blocker probe has lower melting temperature than that of the capture sequence probe.

15. The method of claim 1, wherein the hybrid is captured onto a solid phase.

16. The method of claim 15, wherein the solid phase is coated with streptavidin.

17. The method of claim 15, wherein the solid phase is a microplate.

18. The method of claim 1 or 2, wherein step c) is carried out at room temperature.

19. The method of claim 1 or 2, wherein the bound double-stranded hybrid is detected using an antibody which recognizes a hybrid.

20. The method of claim 19, wherein the hybrid is a DNA-RNA-hybrid.

21. The method of claim 20, wherein the antibody which recognizes a DNA-RNA hybrid is labeled with alkaline-phosphatase.

22. The method of claim 1, wherein the hybrid formed in step a) is captured onto a solid phase.

23. The method of claim 22, wherein the solid phase is coated with streptavidin.

24. The method of claim 22, wherein the solid phase is a microplate.

25. The method of claim 20, wherein the blocker probe is added to the hybridization reaction following the hybridization of the capture sequence probe to the target nucleic acid.

26. The method of claim 20, wherein the blocker probe has lower melting temperature than that of the capture sequence probe.

27. The method according to claim 1, wherein the signal sequence probe comprises a DNA-RNA duplex and a single-stranded nucleic acid sequence which hybridizes to the target nucleic acid.

28. The method according to claim 27, wherein the DNA-RNA duplex is a M13 DNA-M13 RNA duplex.

2. A method of detecting a target nucleic acid comprising:

a) hybridizing a single-stranded target nucleic acid to an immobilized capture sequence probe and a signal sequence probe to form a hybrid complex comprising double-stranded hybrids between said immobilized capture sequence probe and a portion of the target nucleic acid, and between said signal sequence probe and a portion of the target nucleic acid, wherein the capture sequence probe and the signal sequence probe hybridize to non-overlapping regions within the target nucleic acid and do not hybridize to each other;

b) adding a blocker probe to the hybridization reaction, wherein said blocker probe hybridizes to excess non-hybridized capture sequence probes; and

c) detecting the immobilized double-stranded hybrid complex, thereby detecting the target nucleic acid.

4. The method of claim 2, wherein the signal sequence probe is unlabeled.

29. A method of detecting a target nucleic acid comprising:

a) hybridizing a single-stranded target nucleic acid to a capture sequence probe, a bridge probe and a signal sequence probe to form a hybrid complex comprising double-stranded hybrids between said capture sequence probe and a portion of the target nucleic acid, and between said bridge probe and a portion of the target nucleic acid, wherein the capture sequence probe and the bridge probe each hybridize to non-overlapping regions within the target nucleic acid and do not hybridize to each other, and the signal sequence probe hybridizes to the bridge probe and does not hybridize to the target nucleic acid and the capture sequence probe;

b) adding a blocker probe to the hybridization reaction, wherein said blocker probe hybridizes to excess non-hybridized capture sequence probes;

c) capturing the hybrid complex to form a bound double-stranded hybrid complex; and

d) detecting the bound double-stranded hybrid complex, thereby detecting the target nucleic acid.

30. The method according to claim 29, wherein the signal sequence probe comprises a DNA-RNA duplex and a single stranded nucleic acid which hybridizes to the bridge probe.

31. The method according to claim 30, wherein the DNA-RNA duplex is a M13 DNA-M13 RNA duplex.

32. The method according to claim 30, wherein the DNA-RNA duplex is a hybrid formed between repeat sequences within the signal sequence probe and a nucleic acid molecule having complementary sequences to the repeat sequences.

33. The method according to claim 29, wherein the bridge probe further comprises a poly(A) tail.

34. The method according to claim 33, wherein the signal sequence probe comprises a single stranded poly(dT) DNA sequence which hybridizes-to the poly(A) tail of the bridge probe, and a DNA-RNA duplex formed between the poly(dT) sequences in the signal sequence probe and a nucleic acid molecule having poly(A) sequences.